Ronald Petersen, MD, PhD
Mayo Clinic, Rochester, MN
- 14 editions
- 7 talks
- 7 recordings
2026
- Symposium · Chair Integrating Biomarkers, Imaging, and Cognitive Detection in Real-World Diagnosis of Alzheimeru2019s Disease and Related Disorders
2025
- Symposium · Chair UPDATE ON ANTI-AMYLOID TREATMENTS
2024
- Symposium · Chair Implementation of a Treatment Program using Anti-Amyloid Monoclonal Antibodies
2023
- Symposium · Co-Chair Highlights from Observational Studies of Brain Aging (including, cognition, imaging, blood based biomarkers and longitudinal predictors of decline)
2022
- Symposium, Day 1 Reflection on the Concept of MCI and the Evolution of the Term “Adult Cognitive Disorders”
2021
- Symposium, Day 1 Symposium Introductory Notes
- Public Forum My mother has memory loss and has been diagnosed with MCI; are there ways to predict whether, and how quickly, it will progress to dementia?
2020
- Symposium · Keynote NIA-AA Framework for Alzheimer’s Disease Research: Implications for Mild Cognitive Impairment
2019
- Symposium · Moderator Panel Discussion/ Q&A
2018
- Symposium · Chair Cognitive and Brain Reserve
- Symposium Session Overview
2017
- Symposium · Chair Progression Rates in Preclinical and Prodromal Neurodegenerative Disorders
- Symposium Session Overview
- Symposium · Keynote Community Predictors of Progression in Preclinical and MCI Due to Alzheimer's Disease
2016
- Symposium · Moderator MiniSymposium 2 Discussion
2015
- Public Forum Factors which Modify Longevity in MCI and Dementia – the Mayo Clinic Experience
2014
- Symposium The Role of Imaging Biomarkers in the Prediction of MCI and Dementia Due to AD
2013
- Symposium · Discussant Open Discussion
Degrees and affiliation are current where known; the program pages show affiliations as they were each year.